Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

View the agent price guide.

(Bloomberg) -- Bling Capital, a venture firm targeting the earliest of startups, has raised $270 million at a difficult time for most of the venture capital industry. The firm was founded by Ben Ling, ...